Bicara Therapeutics Inc.
BCAX
$22.38
-$0.54-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.30% | -44.28% | 114.17% | 100.51% | 112.51% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -43.44% | 853.04% | 250.36% | -- | 2,305.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.01% | -42.98% | 115.64% | -- | 117.48% |
|
|
|||||
| Total Current Assets | -16.01% | -42.98% | 115.64% | -- | 117.48% |
| Net Property, Plant & Equipment | 140.36% | 286.76% | 280.29% | -- | 3.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.41% | 268.56% | 227.68% | -- | 216.05% |
| Total Assets | -15.49% | -18.98% | 117.25% | -- | 117.96% |
|
|
|||||
| Total Accounts Payable | 41.66% | 86.65% | -37.84% | -- | 22.19% |
| Total Accrued Expenses | 65.43% | 33.25% | 19.48% | -- | 16.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 84.02% | 255.52% | 258.00% | -- | 112.98% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 60.92% | 45.21% | 7.23% | -- | 19.26% |
|
|
|||||
| Total Current Liabilities | 60.92% | 45.21% | 7.23% | -- | 19.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 352.67% | 542.34% | 436.41% | -- | -64.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 63.03% | 49.87% | 12.95% | -- | 17.11% |
|
|
|||||
| Common Stock & APIC | 6.63% | 2.10% | 9,134.12% | -- | 16,666.02% |
| Retained Earnings | -62.42% | -60.74% | -56.23% | -- | -44.44% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -18.38% | -20.95% | 349.00% | 408.50% | 430.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -18.38% | -20.95% | 349.00% | 408.50% | 430.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -18.38% | -20.95% | 126.07% | 110.04% | 125.11% |
|
|
|||||